In a wrinkle-reduction market run by AbbVie’s Botox™ (active ingredient onabotulinumtoxinA), Revance was just approved to distribute DAXXIFY™ (DAXI), a drug that reduces the appearance of facial ...
Credit: Alcon. Access initiatives including a First Fill Free trial program and an ongoing copay support will be available for eligible patients. The active ingredient in Tryptyr is acoltremon, an ...
ZUG, Switzerland, January 21, 2026--(BUSINESS WIRE)--Galderma (SIX:GALD), the pure-play dermatology category leader, today announced that an International Chamber of Commerce arbitral tribunal issued ...
Galderma (SIX: GALD) will present data on its innovative and industry-leading neuromodulator portfolio at the TOXINS 2026 International Conference in Madrid, Spain from January 14-17, 2026. The ...
Letybo ® (Le-tye-boe) is only the 6th neuromodulator to receive approval by the U.S. FDA in over 20 years. Letybo is now fully commercialized in the U.S. through the partnership between BENEV and ...
One of the scariest beauty horror stories out there? Your Botox suddenly stops working. It happened to me about two years ago. I went for my usual round of neuromodulator injections, and noticed that ...
Galderma (SIX:GALD), the pure-play dermatology category leader, today announced that an International Chamber of Commerce arbitral tribunal issued an award confirming the termination of a 2014 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results